116 related articles for article (PubMed ID: 38280656)
1. Cytotoxic effects of kinetin riboside and its selected analogues on cancer cell lines.
Totoń E; Lisiak N; Romaniuk-Drapała A; Framski G; Wyszko E; Ostrowski T
Bioorg Med Chem Lett; 2024 Mar; 100():129628. PubMed ID: 38280656
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative activity of kinetin riboside on HCT-15 colon cancer cell line.
Rajabi M; Gorincioi E; Santaniello E
Nucleosides Nucleotides Nucleic Acids; 2012; 31(6):474-81. PubMed ID: 22646087
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of natural cytokinins: a structure-activity relationship study.
Voller J; Zatloukal M; Lenobel R; Dolezal K; Béres T; Krystof V; Spíchal L; Niemann P; Dzubák P; Hajdúch M; Strnad M
Phytochemistry; 2010 Aug; 71(11-12):1350-9. PubMed ID: 20553699
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of kinetin riboside on mouse, human and plant tumour cells.
Griffaut B; Bos R; Maurizis JC; Madelmont JC; Ledoigt G
Int J Biol Macromol; 2004 Aug; 34(4):271-5. PubMed ID: 15374684
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis of Kinetin Riboside in Colorectal Cancer Cells Occurs by Promoting β-Catenin Degradation.
Nam T; Kang W; Oh S
J Microbiol Biotechnol; 2023 Sep; 33(9):1206-1212. PubMed ID: 37463866
[TBL] [Abstract][Full Text] [Related]
6. Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity.
Tiedemann RE; Mao X; Shi CX; Zhu YX; Palmer SE; Sebag M; Marler R; Chesi M; Fonseca R; Bergsagel PL; Schimmer AD; Stewart AK
J Clin Invest; 2008 May; 118(5):1750-64. PubMed ID: 18431519
[TBL] [Abstract][Full Text] [Related]
7. Could the kinetin riboside be used to inhibit human prostate cell epithelial-mesenchymal transition?
Dulińska-Litewka J; Gąsiorkiewicz B; Litewka A; Gil D; Gołąbek T; Okoń K
Med Oncol; 2020 Feb; 37(3):17. PubMed ID: 32030542
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of kinetin riboside in human heptamoa, HepG2.
Cheong J; Goh D; Yong JW; Tan SN; Ong ES
Mol Biosyst; 2009 Jan; 5(1):91-8. PubMed ID: 19081935
[TBL] [Abstract][Full Text] [Related]
9. The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines.
Cabello CM; Bair WB; Ley S; Lamore SD; Azimian S; Wondrak GT
Biochem Pharmacol; 2009 Apr; 77(7):1125-38. PubMed ID: 19186174
[TBL] [Abstract][Full Text] [Related]
10. Effects of kinetin riboside on proliferation and proapoptotic activities in human normal and cancer cell lines.
Dudzik P; Dulińska-Litewka J; Wyszko E; Jędrychowska P; Opałka M; Barciszewski J; Laidler P
J Cell Biochem; 2011 Aug; 112(8):2115-24. PubMed ID: 21465535
[TBL] [Abstract][Full Text] [Related]
11. [Biological activity of N6-furfuryladenosine].
Wawrzyniak D; Rolle K; Barciszewski J
Postepy Biochem; 2019 Jun; 65(2):109-117. PubMed ID: 31642649
[TBL] [Abstract][Full Text] [Related]
12. Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells.
Choi BH; Kim W; Wang QC; Kim DC; Tan SN; Yong JW; Kim KT; Yoon HS
Cancer Lett; 2008 Mar; 261(1):37-45. PubMed ID: 18162289
[TBL] [Abstract][Full Text] [Related]
13. Circumventing the Crabtree effect: forcing oxidative phosphorylation (OXPHOS) via galactose medium increases sensitivity of HepG2 cells to the purine derivative kinetin riboside.
Orlicka-Płocka M; Gurda-Wozna D; Fedoruk-Wyszomirska A; Wyszko E
Apoptosis; 2020 Dec; 25(11-12):835-852. PubMed ID: 32955614
[TBL] [Abstract][Full Text] [Related]
14. Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones.
Ishii Y; Hori Y; Sakai S; Honma Y
Cell Growth Differ; 2002 Jan; 13(1):19-26. PubMed ID: 11801528
[TBL] [Abstract][Full Text] [Related]
15. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, In Vitro Antitumor Activity and Molecular Mechanism of Novel Furan Derivatives and their Precursors.
Lu D; Zhou Y; Li Q; Luo J; Jiang Q; He B; Tang Q
Anticancer Agents Med Chem; 2020; 20(12):1475-1486. PubMed ID: 32329695
[TBL] [Abstract][Full Text] [Related]
17. The natural cytokinin 2OH3MeOBAR induces cell death by a mechanism that is different from that of the "classical" cytokinin ribosides.
Voller J; Béres T; Zatloukal M; Kaminski PA; Niemann P; Doležal K; Džubák P; Hajdúch M; Strnad M
Phytochemistry; 2017 Apr; 136():156-164. PubMed ID: 28153445
[TBL] [Abstract][Full Text] [Related]
18. Identification of kinetin and kinetin riboside in coconut (Cocos nucifera L.) water using a combined approach of liquid chromatography-tandem mass spectrometry, high performance liquid chromatography and capillary electrophoresis.
Ge L; Yong JW; Goh NK; Chia LS; Tan SN; Ong ES
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):26-34. PubMed ID: 16216563
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design and synthesis of novel furan-diketopiperazine-type derivatives as potent microtubule inhibitors for treating cancer.
Ding Z; Li F; Zhong C; Li F; Liu Y; Wang S; Zhao J; Li W
Bioorg Med Chem; 2020 May; 28(10):115435. PubMed ID: 32278711
[TBL] [Abstract][Full Text] [Related]
20. Theoretical and molecular mechanistic investigations of novel (3-(furan-2-yl)pyrazol-4-yl) chalcones against lung carcinoma cell line (A549).
Mohamed MF; Ibrahim NS; Saddiq AA; Almaghrabi OA; Al-Hazemi ME; Hassaneen HM; Abdelhamid IA
Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):719-736. PubMed ID: 36469109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
